Journal of Korean Medicine Rehabilitation : eISSN 2288-4114 / pISSN 1229-1854

Fig. 1.

Download original image
Fig. 1. Effect of HJT on cell viability in BV2 cells. BV2 cells were treated for 24 h with the vehicle (control) or the indicated concentrations (0.1, 0.25, 0.5, 1, and 2 mg/mL) of HJT. Cell viability was determined by MTT assay, as described in Methods. Data are the mean±standard deviation (n=3). *p<0.05 versus the vehicle-treatment condition. HJT: Hwanggeumjakyak-tang, MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide.
J Korean Med Rehabi 2021;31:1-11 https://doi.org/10.18325/jkmr.2021.31.4.1
© 2021 J Korean Med Rehabi